Protease inhibitor assay
CA 2283434 A1 · Owner: Voyta, John · Inventors: Palmer, Michelle; Tillotson, Bonnie; Voyta, John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Heterogenous and homogenous assays are provided for the detection of protease inhibitory activity in a sample or target compound taking advantage of the , chemiluminescent characteristics of 1,2-dioxetanes. In the heterogenous assay a peptide bearing a cleavage site for the protease of interest is provided with a first member of a first ligand binding pair at one end and a first , member of a second ligand binding pair at the other end. The other member of the first ligand binding pair is attached to a surface which binds the , peptide, or protease substrate to the surface. The peptide substrate is combined with the protease and target compound or sample. Substrate cleavage if not …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 6, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 6, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 6, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.